Search research articles
Contact Us
Filters
Showing results (141-150 of 176) with videos related to
Page
of 18
Sort By:
Dermatologic Therapy
|
October 4, 2019
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation
Vito Di Lernia, Luca Bianchi, Cristina Guerriero, et al.
The Journal of Dermatological Treatment
|
April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Stefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Frontiers in Immunology
|
January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Dermatology and Therapy
|
May 15, 2024
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Biomedicines
|
October 27, 2022
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study
Martina Burlando, Gabriella Fabbrocini, Claudio Marasca, et al.
Expert Opinion on Biological Therapy
|
May 20, 2024
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 25, 2023
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
The Journal of Dermatological Treatment
|
October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs
Giulio Gualdi, Laura Bigi, Clara De Simone, et al.
Dermatology and Therapy
|
June 5, 2026
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis
Luigi Gargiulo, Antonio Costanzo, Piergiorgio Malagoli, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 176) with videos related to
Sort By:
Page
of 18
Dermatologic Therapy
|
October 4, 2019
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation
Vito Di Lernia, Luca Bianchi, Cristina Guerriero, et al.
The Journal of Dermatological Treatment
|
April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Stefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Frontiers in Immunology
|
January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Dermatology and Therapy
|
May 15, 2024
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luigi Gargiulo, Luciano Ibba, et al.
Biomedicines
|
October 27, 2022
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study
Martina Burlando, Gabriella Fabbrocini, Claudio Marasca, et al.
Expert Opinion on Biological Therapy
|
May 20, 2024
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 25, 2023
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
The Journal of Dermatological Treatment
|
October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs
Giulio Gualdi, Laura Bigi, Clara De Simone, et al.
Dermatology and Therapy
|
June 5, 2026
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis
Luigi Gargiulo, Antonio Costanzo, Piergiorgio Malagoli, et al.
Page
of 18